|Institutional Source||Beutler Lab|
|Gene Name||potassium voltage-gated channel, subfamily Q, member 3|
|Is this an essential gene?||Probably non essential (E-score: 0.138)|
|Stock #||R1755 (G1)|
|Chromosomal Location||65986387-66286642 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||A to T at 65995421 bp|
|Amino Acid Change||Leucine to Glutamine at position 791 (L791Q)|
|Ref Sequence||ENSEMBL: ENSMUSP00000063380 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000070256]|
|Predicted Effect||probably damaging
AA Change: L791Q
PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
AA Change: L791Q
|Coding Region Coverage||
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a protein that functions in the regulation of neuronal excitability. The encoded protein forms an M-channel by associating with the products of the related KCNQ2 or KCNQ5 genes, which both encode integral membrane proteins. M-channel currents are inhibited by M1 muscarinic acetylcholine receptors and are activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 2 (BFNC2), also known as epilepsy, benign neonatal type 2 (EBN2). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
PHENOTYPE: Mice homozygous for a null allele exhibit abnormal apamin-insensitive afterhyperpolarization currents in granule cells, but not pyramidal cells, of the hippocampus. Mice homozygous for a knock-in allele exhibit spontaneous seizures and premature death. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Kcnq3||
(F):5'- CAGTGGATGACATAGGCATGGAACC -3'
(R):5'- CATGATCCTGTGAAACTGACCCGAG -3'
(F):5'- CATGGAACCACTGGGTGTG -3'
(R):5'- GGGACCCAGTTCTACAAAGGC -3'